Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) License and Maintenance Revenue (Deprecated 2018-01-31)

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. License and Maintenance Revenue (Deprecated 2018-01-31)

PALATIN TECHNOLOGIES, INC. (PTN) reported License and Maintenance Revenue (Deprecated 2018-01-31) of $10.36 thousand for the 12-month period ending 2013-06-30, per its 10-K filed 2013-09-27.

Discontinued › Income Statement › Other Income

us-gaap:LicenseAndMaintenanceRevenue · last filed 2013-09-27

  • PALATIN TECHNOLOGIES, INC. license and maintenance revenue (deprecated 2018-01-31) for fiscal 2013 was $10.36K, a 85.95% decline from fiscal 2012.
  • PALATIN TECHNOLOGIES, INC. license and maintenance revenue (deprecated 2018-01-31) for fiscal 2012 was $73.74K, a 85.18% decline from fiscal 2011.
  • PALATIN TECHNOLOGIES, INC. license and maintenance revenue (deprecated 2018-01-31) for fiscal 2011 was $497.54K.
Period endLicense and Maintenance Revenue (Deprecated 2018-01-31) 12 month
2013-06-30$10.36K
10-K · filed 2013-09-27
2012-06-30$73.74K
10-K · filed 2013-09-27
2011-06-30$497.54K
10-K · filed 2013-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B